Financials

News Ideas Minds Technicals Forecast

VIRX fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Viracta Therapeutics, Inc.

Total assets of VIRX for Q1 24 is 41.33 M USD, 27.09% less than the previous Q4 23. And total liabilities decreased by 21.16% in Q1 24 to 30.25 M USD.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—